CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 80 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,079,000 | +11.4% | 286,334 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $1,867,000 | +18.8% | 287,248 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $1,571,000 | +51.3% | 287,797 | +29.7% | 0.00% | +100.0% |
Q1 2016 | $1,038,000 | -4.1% | 221,901 | +2.1% | 0.00% | 0.0% |
Q4 2015 | $1,082,000 | +33.6% | 217,369 | +0.9% | 0.00% | 0.0% |
Q3 2015 | $810,000 | -38.8% | 215,377 | -2.2% | 0.00% | -50.0% |
Q2 2015 | $1,323,000 | +49.8% | 220,166 | +39.7% | 0.00% | +100.0% |
Q1 2015 | $883,000 | +89.5% | 157,602 | +1.5% | 0.00% | 0.0% |
Q4 2014 | $466,000 | +11.5% | 155,218 | -0.5% | 0.00% | 0.0% |
Q3 2014 | $418,000 | -5.4% | 155,954 | -1.3% | 0.00% | 0.0% |
Q2 2014 | $442,000 | -31.5% | 158,013 | +6.8% | 0.00% | 0.0% |
Q1 2014 | $645,000 | +37.5% | 147,964 | +1.3% | 0.00% | 0.0% |
Q4 2013 | $469,000 | +98.7% | 146,017 | -1.5% | 0.00% | – |
Q3 2013 | $236,000 | +0.4% | 148,186 | +9.0% | 0.00% | – |
Q2 2013 | $235,000 | – | 135,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |